Effects of deferoxamine-activated hypoxia-inducible factor-1 on the brainstem after subarachnoid hemorrhage in rats

被引:45
作者
Hishikawa, Tomohito [1 ]
Ono, Shigeki [1 ]
Ogawa, Tomoyuki [1 ]
Tokunaga, Koji [1 ]
Sugiu, Kenji [1 ]
Date, Isao [1 ]
机构
[1] Okayama Univ, Grad Sch Med & Dent, Dept Neurol Surg, Okayama 7008530, Japan
关键词
brainstem; cerebral vasospasm; deferoxamine; hypoxia-inducible factor-1; rats; subarachnoid hemorrhage;
D O I
10.1227/01.NEU.0000311082.88766.33
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Hypoxia-inducible factor (HIF)-1 is a transcription factor that regulates the expression of various neuroprotective genes. The goal of this study was to clarify the relationship between HIF-1 expression and subarachnoid hemorrhage (SAH) and to characterize the effects of deferoxamine (DFO)-induced increases in HIF-1 protein levels on the brainstem and the basilar artery (BA) after experimental SAH. METHODS: Rat single- and double-hemorrhage models (injected on Days 0 and 2) of SAH were used. We assessed the time courses for HIF-1 protein levels in the brainstems and the BA diameters within 10 minutes and 6 hours on Days 1 and 2 in the single-SAH model, and also on Day 7 in the double-SAH model. After induction of double hemorrhage in rats, DFO was injected intraperitoneally. We then evaluated HIF-1 protein expression and brainstem activity, BA diameter, and brainstem blood flow. RESULTS: After the rats experienced SAH, HIF-1 protein expression was significantly greater at 10 minutes in the single-injection model and at 7 days in the double-injection model than at similar time points in the control group, and these increases correlated with degrees of cerebral vasospasm. DFO injection resulted in significant increases in HIF-1 protein expression and activity in the brainstems of rats with SAH, compared with the rats with SAH that were given placebos, and the rats without SAH in the double-hemorrhage model. Cerebral vasospasm and reduction of brainstem blood flow were significantly attenuated in the rats that were administered DFO. CONCLUSION: These results show that a DFO-induced increase in HIF-1 protein level and activity exerts significant attenuation of BA vasospasm and reduction of brainstem blood flow in the rat model of SAH. DFO may be a promising agent for treating clinical SAH.
引用
收藏
页码:232 / 240
页数:9
相关论文
共 43 条
[1]   REVERSAL OF EXPERIMENTAL ACUTE CEREBRAL VASOSPASM BY ANGIOTENSIN CONVERTING ENZYME-INHIBITION [J].
ANDREWS, P ;
PAPADAKIS, N ;
GAVRAS, H .
STROKE, 1982, 13 (04) :480-483
[2]   Systemic administration of the iron chelator deferiprone attenuates subarachnoid hemorrhage-induced cerebral vasospasm in the rabbit [J].
Arthur, AS ;
Fergus, AH ;
Lanzino, G ;
Mathys, J ;
Kassell, NF ;
Lee, KS .
NEUROSURGERY, 1997, 41 (06) :1385-1391
[3]  
Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO
[4]  
2-8
[5]  
Chavez JC, 2002, J NEUROSCI, V22, P8922
[6]   SUBARACHNOID HEMORRHAGE IN THE RAT - ANGIOGRAPHY AND FLUORESCENCE MICROSCOPY OF THE MAJOR CEREBRAL-ARTERIES [J].
DELGADO, TJ ;
BRISMAR, J ;
SVENDGAARD, NA .
STROKE, 1985, 16 (04) :595-602
[7]   Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage [J].
Grasso, G ;
Buemi, M ;
Alafaci, C ;
Sfacteria, A ;
Passalacqua, M ;
Sturiale, A ;
Calapai, G ;
De Vico, G ;
Piedimonte, G ;
Salpietro, FM ;
Tomasello, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (08) :5627-5631
[8]   INHIBITION OF DELAYED ARTERIAL NARROWING BY THE IRON-CHELATING AGENT DEFEROXAMINE [J].
HARADA, T ;
MAYBERG, MR .
JOURNAL OF NEUROSURGERY, 1992, 77 (05) :763-767
[9]   Role of ferrous iron chelator 2,2′-dipyridyl in preventing delayed vasospasm in a primate model of subarachnoid hemorrhage [J].
Horky, LL ;
Pluta, RM ;
Boock, RJ ;
Oldfield, EH .
JOURNAL OF NEUROSURGERY, 1998, 88 (02) :298-303
[10]   Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron [J].
Hua, Y ;
Keep, RF ;
Hoff, JT ;
Xi, GH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2003, 23 (12) :1448-1454